Ionis Pharmaceuticals Inc (IONS) — Capital Reinvestment Ratio
Latest as of June 2025:
0.09x
Ionis Pharmaceuticals Inc (IONS) has a Capital Reinvestment Ratio of 0.09x as of June 2025, meaning it reinvests 0% of its operating cash flow ($151.34 Million) in capital expenditures ($14.27 Million). See Ionis Pharmaceuticals Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.09x
Capex / Operating Cash Flow
Operating Cash Flow
$151.34 Million
USD
Capital Expenditures
$14.27 Million
USD
Data as of
Jun 2025
Most recent filing
Ionis Pharmaceuticals Inc Capital Reinvestment Ratio (2007–2021)
This chart tracks Ionis Pharmaceuticals Inc's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Ionis Pharmaceuticals Inc (2007–2021)
Year-by-year Capital Reinvestment Ratio for Ionis Pharmaceuticals Inc from 2007 to 2021. For live market cap and broader valuation context, see IONS company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.58x | $30.80 Million | $17.90 Million | ▼ -49.2% |
| 2020 | 1.14x | $35.89 Million | $41.05 Million | ▲ +989.8% |
| 2019 | 0.10x | $345.72 Million | $36.28 Million | ▲ +258.4% |
| 2018 | 0.03x | $602.89 Million | $17.65 Million | ▼ -86.5% |
| 2017 | 0.22x | $174.15 Million | $37.86 Million | ▼ -60.9% |
| 2015 | 0.56x | $21.12 Million | $11.75 Million | ▼ -68.5% |
| 2014 | 1.77x | $6.29 Million | $11.10 Million | ▲ +1992.1% |
| 2013 | 0.08x | $63.49 Million | $5.36 Million | ▼ -96.9% |
| 2012 | 2.76x | $1.88 Million | $5.17 Million | ▲ +3323.7% |
| 2008 | 0.08x | $212.03 Million | $17.07 Million | ▼ -42.0% |
| 2007 | 0.14x | $36.09 Million | $5.01 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow